Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Ann Hepatol ; 29(3): 101490, 2024.
Article in English | MEDLINE | ID: mdl-38403070

ABSTRACT

INTRODUCTION AND OBJECTIVES: Intrahepatic cholestasis of pregnancy (ICP) is often accompanied by fetal and maternal complications. MATERIALS AND METHODS: Retrospective review of the clinical course of women with ICP and their neonates treated at our medical center over a 10-year period. Special attention was paid to the maternal and neonatal response to 2 different modes of ursodeoxycholic acid (UDCA) administration. RESULTS: Neonates of mothers with high total bile acid levels had a poorer composite neonatal outcome. Twenty-seven women who presented at an advanced stage of their pregnancies did not receive UDCA. UDCA was administered in 2 modes: either a full dose at admission (76 women) or a gradually increasing dose until the desired dosage was reached (25 women). The mean gestational age at delivery for the 94 neonates that were exposed to full UDCA dose was the lowest (36±2.3 weeks for the full dose, 37±1.4 weeks for the 30 neonates from the gradually increasing dose, 38±1.6 weeks for the 29 neonates from the no treatment group, p<0.001). The group of neonates that were exposed to full UDCA dose had the highest rate of unfavorable composite neonatal outcome (53% for full dose, 30% for gradually increasing dose, 24% for the no treatment group, p=0.006). CONCLUSIONS: Compared to the administration of a full UDCA dose, the administration of a gradually increasing dose of UDCA may be associated with a greater gestational age at delivery and fewer events of unfavorable composite neonatal outcomes. These novel findings should be retested prospectively in a large cohort of patients.


Subject(s)
Cholagogues and Choleretics , Cholestasis, Intrahepatic , Gestational Age , Pregnancy Complications , Ursodeoxycholic Acid , Humans , Ursodeoxycholic Acid/administration & dosage , Ursodeoxycholic Acid/therapeutic use , Female , Pregnancy , Cholestasis, Intrahepatic/drug therapy , Cholestasis, Intrahepatic/diagnosis , Cholestasis, Intrahepatic/blood , Retrospective Studies , Pregnancy Complications/drug therapy , Pregnancy Complications/blood , Infant, Newborn , Cholagogues and Choleretics/administration & dosage , Cholagogues and Choleretics/adverse effects , Cholagogues and Choleretics/therapeutic use , Adult , Treatment Outcome , Pregnancy Outcome
2.
Curr Neuropharmacol ; 19(6): 896-906, 2021.
Article in English | MEDLINE | ID: mdl-33655866

ABSTRACT

BACKGROUND AND OBJECTIVE: An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to study this association and to look for sources of bias by performing a systematic review and meta-analysis. METHODS: Medline, Embase, and the Cochrane Library were searched up to June 2019 for studies reporting on ASD and ADHD in the Offspring following exposure during pregnancy. We followed the PRISMA 2009 guidelines for data selection and extraction. Outcomes were pooled using random- effects models and odds ratios (OR), and 95% confidence intervals (CI) were calculated for each outcome using the adjusted point estimate of each study. RESULTS: Eighteen studies were included in the meta-analysis. We found an association between SSRIs/ SNRIs prenatal use and the risk for ASD and ADHD (OR=1.42, 95% CI: 1.23-1.65, I2=58%; OR=1.26, 95% CI: 1.07-1.49, I2=48%, respectively). Similar findings were obtained in women who were exposed to SSRIs/SNRIs before pregnancy, representing statistically significant association with ASD (OR=1.39, 95% CI: 1.24-1.56, I2=33%) and ADHD (OR=1.63, 95% CI: 1.50-1.78, I2=0%) in the Offspring, although they were not exposed to those medications in utero. CONCLUSIONS: Although we found an association between exposure to SSRIs/SNRIs during pregnancy and the risk for ASD and ADHD, an association with those disorders was also present for exposure pre-pregnancy, suggesting that the association might be due to unmeasured confounding. We are aiming to further assess the role of potential unmeasured confounding in the estimation of the association and perform a network meta-analysis.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Autism Spectrum Disorder , Prenatal Exposure Delayed Effects , Serotonin and Noradrenaline Reuptake Inhibitors , Attention Deficit Disorder with Hyperactivity/epidemiology , Autism Spectrum Disorder/chemically induced , Female , Humans , Norepinephrine , Pregnancy , Serotonin , Selective Serotonin Reuptake Inhibitors/adverse effects
3.
Infant Behav Dev ; 58: 101421, 2020 02.
Article in English | MEDLINE | ID: mdl-32135402

ABSTRACT

BACKGROUND: The current study aims to evaluate the association between preterm birth and the quality of mother-child interaction of very preterm-, moderate preterm-, and full-term-born children at 18 and 36 months and to determine whether developmental and behavioral characteristics mediate the association between preterm birth and the quality of mother-child interaction. METHOD: Participants included 110 preterm-born children and 39 full-term-born children assessed at ages 18 and 36 months. Mother-child free play interactions, the Mullen Scales of Early Learning, the Infant Behavior Questionnaire, and the Early Childhood Behavior Questionnaire were administered. RESULTS: Significant associations between preterm birth and the quality of mother-child interaction were found at 18 and 36 months. The mother-child interaction quality was less optimal for the preterm-born children compared with the full-term-born children, mainly so for the very preterm-born children. Unlike behavioral characteristics, cognitive development was found to mediate the association between the gestational age-based group and the quality of mother-child interaction. CONCLUSIONS: Intervention programs for preterm-born children and their families, should consider maternal and children's behaviors during mother-child interactions, in addition to cognitive, language, motor and emotional regulation abilities, and particularly so with very preterm-born children, who exhibit slower cognitive development.


Subject(s)
Child Development/physiology , Infant, Premature/physiology , Infant, Premature/psychology , Mother-Child Relations/psychology , Temperament/physiology , Adult , Child, Preschool , Female , Humans , Infant , Infant Behavior/physiology , Infant Behavior/psychology , Infant, Newborn , Male , Middle Aged , Surveys and Questionnaires , Young Adult
4.
J Infect Dis ; 220(11): 1790-1796, 2019 10 22.
Article in English | MEDLINE | ID: mdl-31310307

ABSTRACT

BACKGROUND: Saliva real-time polymerase chain reaction (PCR) was shown to be sensitive and specific for the detection of congenital cytomegalovirus (cCMV) in universal screening studies. In the current study, we assessed the performance of saliva real-time PCR in newborns undergoing targeted cCMV screening. METHODS: Saliva real-time PCR results were prospectively correlated with reference-standard urine detection in newborns undergoing targeted cCMV screening over a 3-year period, in successive validation (concurrent testing of all saliva and urine specimens) and routine-screening (confirmatory urine testing of positive saliva results) implementation phases. RESULTS: The sensitivity, specificity, and positive and negative predictive values of saliva real-time PCR were 98.3% (95% confidence interval, 90.8%-99.9%), 91.5% (89.3%-93.3%), 45.6% (36.7%-54.7%), and 99.9% (99.2%-99.9%), respectively, in 856 concurrently tested newborns. True-positive saliva real-time PCR detection (defined in relation to urine detection) was associated with earlier saliva sampling (P = .002) and a higher saliva viral load (P < .001). We further identified a saliva viral load cutoff value that reliably distinguished between true-positive and false-positive saliva results. CONCLUSIONS: In newborns undergoing targeted screening for cCMV, saliva real-time PCR is highly sensitive yet has a low positive predictive value, necessitating confirmatory testing. Early sampling and application of a validated viral load cutoff could improve the assay performance and support its large-scale implementation in this growing clinical setting.


Subject(s)
Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/diagnosis , Cytomegalovirus/isolation & purification , Mass Screening/methods , Molecular Diagnostic Techniques/methods , Real-Time Polymerase Chain Reaction/methods , Saliva/virology , Female , Humans , Infant, Newborn , Male , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity
5.
Am J Obstet Gynecol ; 220(1): 57.e1-57.e13, 2019 01.
Article in English | MEDLINE | ID: mdl-30170040

ABSTRACT

BACKGROUND: There is a marked increase in the use of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors in the last decade. Many newborns are likely to be exposed during pregnancy and labor. OBJECTIVE: We aimed to evaluate the association between exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors during pregnancy and the risk for persistent pulmonary hypertension of the newborn. We sought to compare the risk for persistent pulmonary hypertension of the newborn between specific selective serotonin reuptake inhibitor agents. STUDY DESIGN: MEDLINE, Embase, and Cochrane were searched up to July 2017. No language restrictions were applied. Search key words included: "SSRI," "SNRI," "pregnancy," "risk," "new-born," and "pulmonary hypertension." Retrospective cohort studies and case-control studies reporting the risk for persistent pulmonary hypertension of the newborn in the offspring of women exposed to selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors during pregnancy, were extracted. Two independent researchers identified relevant data. Random effects meta-analysis was used to pool results. Odds ratios were calculated with subsequent 95% confidence intervals. Network meta-analysis was conducted, incorporating direct and indirect comparisons among different selective serotonin reuptake inhibitors. The primary outcome was risk for persistent pulmonary hypertension of the newborn after exposure to selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors during pregnancy. RESULTS: A total of 11 studies were identified. A total of 156,978 women and their offspring were exposed to selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors during pregnancy. Persistent pulmonary hypertension of the newborn was detected among 452 exposed offspring, representing an incidence rate of 2.9 cases per 1000 live births and a number needed to harm of 1000. The risk for persistent pulmonary hypertension of the newborn was significantly increased in the analysis of exposure to selective serotonin reuptake inhibitor/serotonin norepinephrine reuptake inhibitor in any trimester (odds ratio, 1.82; 95% confidence interval, 1.31-2.54; I2 = 72%), as well as in analysis restricted to exposure week >20 (odds ratio, 2.08; 95% confidence interval, 1.44-3.01; I2 = 76%). In network meta-analysis, sertraline was ranked most likely to have the lowest risk for persistent pulmonary hypertension of the newborn among the different selective serotonin reuptake inhibitors (P = .83). CONCLUSION: Exposure to selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors during pregnancy is associated with an increased risk for persistent pulmonary hypertension of the newborn. According to our findings, sertraline ranked as most likely to have the lowest risk for persistent pulmonary hypertension of the newborn compared to other selective serotonin reuptake inhibitors, suggesting it may have the best safety profile for use in pregnancy in this regard. Further studies are needed to fully establish these results.


Subject(s)
Depressive Disorder/drug therapy , Norepinephrine/antagonists & inhibitors , Persistent Fetal Circulation Syndrome/chemically induced , Prenatal Exposure Delayed Effects/chemically induced , Selective Serotonin Reuptake Inhibitors/adverse effects , Depressive Disorder/diagnosis , Female , Follow-Up Studies , Gestational Age , Humans , Incidence , Infant, Newborn , Network Meta-Analysis , Norepinephrine/administration & dosage , Persistent Fetal Circulation Syndrome/epidemiology , Persistent Fetal Circulation Syndrome/physiopathology , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/drug therapy , Pregnancy Trimester, Third , Prenatal Exposure Delayed Effects/physiopathology , Risk Assessment , Selective Serotonin Reuptake Inhibitors/administration & dosage
6.
Autism Res Treat ; 2018: 8316212, 2018.
Article in English | MEDLINE | ID: mdl-30534432

ABSTRACT

BACKGROUND: The aim of this study was to examine the long-term risk for autism spectrum disorders (ASD) in individuals who are born preterm and full-term using both observational instruments and parental reports. Neonatal risk factors and developmental characteristics associated with ASD risk were also examined. METHOD: Participants included 110 preterm children (born at a gestational age of ≤ 34 weeks) and 39 full-term children assessed at ages 18, 24, and 36 months. The Autism Diagnostic Observation Schedule, the Modified Checklist for Autism in Toddlers, the Autism Diagnostic Interview-Revised, the Social Communication Questionnaire, and the Mullen Scales of Early Learning were administered. RESULTS AND CONCLUSIONS: The long-term risk for ASD was higher when parental reports were employed compared to observational instruments. At 18 and 24 months, a higher long-term risk for ASD was found for preterm children compared to full-term children. At 36 months, only one preterm child and one full-term child met the cutoff for ASD based on the ADOS, yet clinical judgment and parental reports supported an ASD diagnosis for the preterm child only. Earlier gestational age and lower general developmental abilities were associated with elevated ASD risk among preterm children.

7.
BMJ Open ; 8(7): e021749, 2018 07 06.
Article in English | MEDLINE | ID: mdl-29982217

ABSTRACT

INTRODUCTION: Retinopathy of prematurity (ROP) is a disease observed in extremely premature infants characterised by visioning-threatening retinal vessel proliferation. Propranolol, a drug used for decades in newborn infants with heart diseases, hypertension and thyrotoxicosis and licenced for infantile haemangiomas, may be effective in halting progression of ROP to severe stages, as suggested by preliminary data from small studies. METHODS AND ANALYSIS: ROPROP is an investigator-initiated, multicentre, placebo-controlled double-blind, randomised controlled trial aiming to assess the safety and efficacy of orally administered propranolol to reduce the risk of threshold ROP (stage 3) in extremely preterm infants at 48 weeks postmenstrual age (primary objective) and the rate of infants requiring local interventions for severe ROP (secondary objective). Key inclusion criteria: gestational age <28 weeks, birth weight <1250 g, postmenstrual age ≥31 and <37 weeks, incipient ROP (stage 1 or 2, with or without plus disease) and written informed consent by parents or legal guardian. Key exclusion criteria: requirement for open-label propranolol treatment, major congenital malformations (including those with cerebrovascular malformations), known chromosomal anomalies, colobomas and other eye malformations, atrioventricular block grade 2 or 3 and comedication with antiarrhythmics, clonidine, insulin (pharmacodynamic interaction), phenobarbital or rifampicin (pharmacokinetic interaction). The intervention consists of oral propranolol-hydrochloride (1.6 mg/kg/day in three to four divided dosages) or placebo until discharge, for a maximum of 10 weeks. Analysis is by intention to treat. ETHICS AND DISSEMINATION: The protocol has received ethical and regulatory approval. Results will be published after peer review irrespective of the study outcome. TRIAL REGISTRATION NUMBERS: NCT03083431 , EudraCT# 2017-002124-24 (EUCTR), 00013730 (DRKS); Pre-results.


Subject(s)
Adrenergic beta-Antagonists/administration & dosage , Propranolol/administration & dosage , Retinopathy of Prematurity/prevention & control , Administration, Oral , Disease Progression , Double-Blind Method , Gestational Age , Humans , Infant , Infant, Extremely Premature , Infant, Newborn , Infant, Very Low Birth Weight , Randomized Controlled Trials as Topic , Treatment Outcome
8.
Res Dev Disabil ; 80: 35-43, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29906778

ABSTRACT

The aim of this study is to examine the effect of age correction on the developmental assessment scores of preterm infants, using for the first time, the Mullen scales of early learning (MSEL) test. Participants included 110 preterm infants (born at a gestational age of ≤ 34 weeks) at ages 1, 4, 8, 12, 18, 24 and 36 months. The corrected age-based MSEL composite score and each of the five MSEL scale scores were significantly higher than chronological age-based scores at all ages. These corrected scores were significantly higher than the chronological scores regardless of gestational age whether weight was, or adequate or small for gestational age. Larger differences between corrected and chronological age-based scores significantly correlated with earlier gestational age and with lower birth weight between 1 and 24 months but not at 36 months. Using chronological age-based scores yielded significantly more infants identified with developmental delays than using corrected age-based scores. The findings indicate that clinicians and researchers, as well as family members, should be aware of and acknowledge the distinction between corrected and chronological ages when evaluating preterm infants in research and clinical practices.


Subject(s)
Child Development , Developmental Disabilities/diagnosis , Gestational Age , Age Factors , Child, Preschool , Female , Humans , Infant , Infant, Extremely Premature , Infant, Premature , Male
9.
Infant Behav Dev ; 52: 56-65, 2018 08.
Article in English | MEDLINE | ID: mdl-29864604

ABSTRACT

Very-preterm (VPT), moderately-preterm (MPT), and full-term (FT) infants' emotion-regulation behaviors were assessed via the Still-Face procedure at a corrected age of four months. As a developmental task during the first year of life, emotion regulation is important for social and cognitive development. Although substantial evidence indicates that VPT infants exhibit emotion-regulation difficulties, little is known about MPT infants' emotion regulation capabilities, this group also possibly being at risk. The participants included 135 parent-infant dyads: 46 VPT (gestational age 24-32 weeks), 51 MPT (gestational age 32-34 weeks), and 38 FT (gestational age 37-41 weeks). The infants' affect, gaze-aversion, and self-comforting behaviors were coded. Preterm infants responded to parental still face in similar fashion to FT infants, displaying robust still-face and recovery effects. The preterm infants exhibited less developed emotion-regulation behaviors, however, manifested in less positive affect and more gaze aversion in the face-to-face and reunion episodes compared to FT infants. With respect to self-comforting behaviors, each group displayed a significantly different pattern of behaviors throughout the procedure, suggesting better emotion regulation skills among MPT infants compared to the VPT infants. The findings on gaze aversion and self-comforting behaviors could have implications for strategies to incorporate into intervention programs supporting development of emotion regulation skills.


Subject(s)
Emotions , Infant Behavior/psychology , Infant, Premature/psychology , Parent-Child Relations , Affect , Child Development/physiology , Cognition , Female , Gestational Age , Humans , Infant , Infant, Newborn , Male , Parents
10.
Harefuah ; 157(3): 170-174, 2018 Mar.
Article in Hebrew | MEDLINE | ID: mdl-29582948

ABSTRACT

INTRODUCTION: : Minimally invasive fetal therapeutic procedures reduce the morbidity and mortality in monochorionic (MC) twins and in fetuses with congenital diaphragmatic hernia (CDH). MC pregnancies share their blood systems due to communicating vessels over their single placenta and may develop specific complications: Twin-to-Twin transfusion syndrome (TTTS), Selective intrauterine growth restriction (sIUGR), Twin Anemia-Polycythemia Sequence (TAPS), Twin Reverse Arterial Perfusion Syndrome (TRAP) or anomalies in one. Half of complicated MC require intrauterine interventions. Severe CDH is linked to a high rate of neonatal death due to pulmonary hypoplasia. Fetoscopic tracheal occlusion (FETO) with a balloon improves postnatal outcome. AIMS: A fetal therapy center was established in the Hadassah Medical Centers, Jerusalem in 2011 for intrauterine interventions. We report our 5 years' experience. METHODS: This prospective cohort follows the outcome of MC pregnancies and cases of severe CDH which underwent therapeutic fetal procedures in Hadassah between the years 2011-16. RESULTS: Out of 114 procedures, 95 were in MC: 84 monochorionic diamniotic twins, 7 monochorionic monoamniotic twins, 2 dichorionic triamniotic triplets and 2 monochorionic triplets. We treated 65 TTTS cases with fetoscopy and laser ablation of communicating vessels. The survival rate of both twins was 58.5% and at least one survived in 81.5% of the cases. In 2nd/3rd trimesters selective termination of 15 cases the survival rate of the remaining twin was 87%. In 11 cases of TRAP sequence treated with laser ablation of the feeding vessel the survival of the remaining twin was 91%. In 19 fetoscopies in severe CDH, 12 were for balloon insertion and 7 for removal. Endotracheal balloon was successfully placed in 11 of 12 cases (10 left-sided, 1 right-sided CDH). Balloon removal was prenatally performed by elective fetoscopy (n=7) or by intrapartum urgent puncture. There were no intrauterine fetal deaths. In isolated left-sided CDH the survival was 57%, whereas none survived in non-isolated left-sided CDH and right sided CDH. CONCLUSIONS: In-utero procedures are safe for the mother and increase newborn survival in MC pregnancies, thus specialized clinics are life-saving. FETO is a therapeutic option for severe CDH. Our results meet similar achievements reported by other leading world centers.


Subject(s)
Fetofetal Transfusion/surgery , Hernias, Diaphragmatic, Congenital/therapy , Placenta/blood supply , Balloon Occlusion/methods , Female , Fetal Diseases/surgery , Fetal Diseases/therapy , Fetoscopy/methods , Hernias, Diaphragmatic, Congenital/surgery , Humans , Infant, Newborn , Laser Therapy , Placenta Diseases/surgery , Pregnancy , Prospective Studies
11.
Res Dev Disabil ; 81: 12-23, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29113755

ABSTRACT

BACKGROUND AND OBJECTIVES: Preterm infants are at risk for neuro-developmental impairments and atypical developmental trajectories. The aims of this study were to delineate early developmental trajectories of preterm and full-term infants. METHODS: The cognitive, language, and motor development of 149 infants - 19 extremely preterm (EPT), 34 very preterm (VPT), 57 moderately preterm (MPT), and 39 full-term (FT) - was evaluated using Mullen Scales at 1, 4, 8, 12, and 18 months. Mixed models were applied to examine group differences. Gender, maternal education, and neurobehavior were included as predictors of developmental trajectories. RESULTS: The EPT and VPT infants achieved significantly lower scores than the FT infants in all domains, with a significantly increasing gap over time. The MPT infants' trajectories were more favorable than those of the EPT and VPT infants yet lower than the FT infants on the Visual Reception, Gross, and Fine Motor subscales. Male gender and lower maternal education were associated with lower scores that declined over time. Abnormal neonatal neurobehavior was associated lower Mullen scores and with less stability in scores over time. CONCLUSIONS: The EPT and VPT infants were found to have disadvantages across all domains. The MPT infants revealed more favorable developmental trajectories yet displayed vulnerability compared to the FT infants. Gender, maternal education, and neonatal neurobehavior are important in predicting the developmental outcomes of preterm infants.


Subject(s)
Cognition , Developmental Disabilities , Infant, Extremely Premature/growth & development , Infant, Premature/growth & development , Language Development , Motor Skills , Child Development , Correlation of Data , Developmental Disabilities/diagnosis , Developmental Disabilities/epidemiology , Developmental Disabilities/etiology , Educational Status , Female , Humans , Infant , Infant, Newborn , Male , Mental Status and Dementia Tests , Risk Factors , Sex Factors
12.
Pediatr Res ; 82(6): 958-963, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28738027

ABSTRACT

BackgroundTo validate the findings of a single-center pilot study showing elevated urinary N-terminal B-type natriuretic peptide (NTproBNP) concentrations in preterm infants subsequently developing severe retinopathy of prematurity (ROP) in a multicenter setting across eight European and Middle East countries.MethodsProspective observational study in 967 preterm infants <30 weeks' gestational age assessing the capacity of urinary NTproBNP on days of life (DOLs) 14 and 28 to predict ROP requiring treatment.ResultsUrinary NTproBNP concentrations were markedly elevated in infants who developed ROP requiring treatment (n=94) compared with survivors without ROP treatment (n=837), at both time points (median (interquartile range) DOL14: 8,950 (1,925-23,783) vs. 3,083 (1,193-17,393) vs. 816 (290-3,078) pg/ml, P<0.001) and DOL28 (2,203 (611-4,063) vs. 1,671 (254-11,340) vs. 408 (162-1,126) pg/ml, P<0.001). C-statistic of NTproBNP for treated ROP or death was 0.731 (95% confidence interval 0.654-0.774) for DOL14 and 0.683 (0.622-0.745) for DOL28 (P<0.001). Threshold scores were calculated, potentially enabling around 20% of infants with low NTproBNP scores never to be screened with ophthalmoscopy.ConclusionThere is a strong association between early urinary NTproBNP and subsequent ROP development, which can be used to further refine subgroups of patients with high or low risk of severe ROP.


Subject(s)
Natriuretic Peptide, Brain/urine , Retinopathy of Prematurity/urine , Female , Humans , Infant, Newborn , Infant, Premature , Male , Pilot Projects , Prospective Studies , Retinopathy of Prematurity/diagnosis , Retinopathy of Prematurity/physiopathology , Survival Analysis
13.
Attach Hum Dev ; 19(5): 487-503, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28504008

ABSTRACT

Preterm birth can be traumatic for some mothers, involving feelings of grief over the hoped-for full-term pregnancy. In this longitudinal study, we interviewed 50 mothers of preterm infants, using the reaction to diagnosis interview when their child was 1 month and 18 months old. We examined change and stability in resolution status over time. Additionally, we explored possible predictors of resolution trajectories between 1 and 18 months. Findings indicated that resolution at 1 month was not yet common. The rate of resolution at 18 months was 62.6%, compared with 38.2% at 1 month. Prenatal precursors of preterm birth, lower medical neonatal risk, and lower maternal stress at 1 month significantly differentiated mothers who attained resolution as early as at 1 month from those who were unresolved at 1 and 18 months. Lower maternal stress at 1 month was the only predictor that significantly differentiated initially unresolved mothers who later attained resolution from those who remained unresolved at 18 months. Discussion focuses on maternal stress, which may mark a subgroup of mothers of preterm infants who are at risk of being unresolved through the first 18 months, and who may benefit from resolution-focused intervention.


Subject(s)
Infant, Premature , Premature Birth/psychology , Resilience, Psychological , Adaptation, Psychological , Adult , Female , Grief , Humans , Infant , Interviews as Topic , Longitudinal Studies , Mother-Child Relations/psychology , Object Attachment , Risk Factors , Socioeconomic Factors , Stress, Psychological/psychology , Time Factors
14.
Int J Qual Health Care ; 29(3): 366-370, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28340029

ABSTRACT

OBJECTIVE: To evaluate the rate of medication related errors in the pediatric ward and pediatric emergency department (PED), before and after implementing intervention strategies according to the Joint Commission International (JCI) accreditation program. DESIGN: A retrospective cross-sectional study that included chart review. SETTING: A university affiliated pediatric ward and PED. PARTICIPANTS: Children 0-18 years old admitted on February 2013 (before the JCI program) and February 2014 (during implementation of the JCI program). INTERVENTION(S): A training program designed to meet the JCI official standards on medication prescribing. MAIN OUTCOME MEASURE(S): The number of prescribing and medication administration errors in the 2 years. RESULTS: We collected 937 valid prescription orders and 924 administration orders (1861 medical orders) from February 2013, and 961 valid prescription orders and 958 administration orders (1919 medical orders) from February 2014. There was a significant reduction in prescribing errors from 6.5 to 4.2% between years 2013 and 2014 (P = 0.03). There was no significant difference in administration error rates between the two periods (104 (11.3%) in the first period and 114 (11.9%) in the second; P = 0.61). CONCLUSIONS: The errors rate we found was within the range described in the literature. Quality assurance interventions can significantly reduce medication prescribing errors.


Subject(s)
Accreditation , Medication Errors/statistics & numerical data , Pharmacy Service, Hospital/standards , Academic Medical Centers , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Emergency Service, Hospital/standards , Humans , Infant , Infant, Newborn , Israel , Retrospective Studies
15.
Neonatology ; 111(3): 240-246, 2017.
Article in English | MEDLINE | ID: mdl-27898422

ABSTRACT

BACKGROUND: The American Academy of Pediatrics (AAP) recently narrowed the indications for respiratory syncytial virus (RSV) prophylaxis, while in Israel the guidelines have not changed. OBJECTIVE: To compare the prevalence and severity of RSV infection among preterm infants born earlier than 340/7 weeks of gestation (PI), late preterm infants born at 340/7-366/7 weeks (LPTI), and term infants born after 370/7 weeks of gestation (TI) and to determine whether the results support a change in local policy. METHODS: Data of all children aged 0-14 years hospitalized with PCR-positive RSV in a single tertiary center from 2010 to 2014 were collected. A total of 793 children were included and divided into 3 groups: 637 were TI, 105 were LPTI, and 50 were PI. These groups were compared regarding incidence of hospitalization due to RSV infection, intensive care unit (ICU) hospitalization, and length of hospitalization. RESULTS: The hospitalization rate due to RSV infection was 5.2, 3.5, and 1.3% among PI, LPTI, and TI, respectively (p < 0.01). The hospitalization rate in the ICU was 24, 7.6, and 3% among PI, LPTI, and TI, respectively (p < 0.001). The length (days) of hospitalization was significantly longer among PI compared with LPTI and TI (p < 0.001). Overall, the hospitalization rate and disease severity were significantly higher for infants born earlier than 35 weeks of gestation compared with more maturely born infants. CONCLUSION: RSV infection remains a major cause of morbidity among children born prematurely even after RSV prophylaxis and would probably be greater were prophylaxis curtailed. Our results do not support applying the current AAP guidelines in Israel. Further local studies are needed to optimize prophylaxis for both PI and LPTI.


Subject(s)
Hospitalization/statistics & numerical data , Infant, Premature , Respiratory Syncytial Virus Infections/therapy , Female , Gestational Age , Humans , Infant , Infant, Newborn , Intensive Care Units , Israel , Male , Practice Guidelines as Topic , Respiratory Syncytial Viruses , Retrospective Studies , Severity of Illness Index , Tertiary Care Centers
16.
Harefuah ; 155(1): 15-9, 68, 2016 Jan.
Article in Hebrew | MEDLINE | ID: mdl-27012068

ABSTRACT

INTRODUCTION: Early prediction of late onset sepsis is imperative in order to improve survival and reduce long-term complications. Since clinical deterioration is detrimental, empiric antibiotic treatment is initiated once sepsis is suspected. Symptoms that may indicate invasive infection are non-specific. Previous risk scores offered to improve clinical decision-making but provided low predictive values. AIMS: To evaluate the quantitative early alert of software application compared to clinical judgment by the treating physician, and the "gold standard" of positive blood and/or positive cerebrospinal fluid. METHODS: Weight, heart and respiratory rates, episodes of bradycardia and desaturation, and temperature were collected for each neonate and loaded daily into the system for a period of 30 days by a registered nurse. The medical team and the registered nurse were blind to the system alerts. Analysis of the correlation between the software alerts, the clinical suspicion of sepsis and bacteremia was conducted. RESULTS: Forty-five very low birth weight consecutively born infants who did not have early onset sepsis and survived, were evaluated, of whom 17 infants had culture proven bloodstream infection. The software positive predictive value was 6%, 23%, 31%, at 12, 24, 48, hours respectively for alerts approximately to positive cultures. The positive predictive value of clinical suspicion of LOS was 28% but increased from 25% with low levels of clinical suspicion to 34% with high levels of clinical suspicion. DISCUSSION: The software application did not improve sepsis prediction. However, further trials may develop a more accurate algorithm that will alert the physician to be more attentive to infants in special cases.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/epidemiology , Sepsis/epidemiology , Algorithms , Bacteremia/drug therapy , Female , Humans , Infant, Very Low Birth Weight , Male , Predictive Value of Tests , Sepsis/drug therapy , Software
17.
Harefuah ; 155(1): 20-3, 68, 2016 Jan.
Article in Hebrew | MEDLINE | ID: mdl-27012069

ABSTRACT

Respiratory Syncytial Virus (RSV is the most common cause of respiratory infections in infants, causing bronchiolitis and pneumonia. Premature infants have an increased risk for developing severe illness and even death. A monoclonal antibody vaccination named Palivizumab is available for preventing RSV infection. We describe an outbreak and control of RSV infections in one of our neonatal intensive care units, involving three patients and two medical team members.


Subject(s)
Disease Outbreaks/prevention & control , Intensive Care Units, Neonatal , Respiratory Syncytial Virus Infections/prevention & control , Humans , Male , Palivizumab/administration & dosage , Patient Care Team , Respiratory Syncytial Virus Infections/epidemiology
18.
Autism ; 20(7): 856-67, 2016 10.
Article in English | MEDLINE | ID: mdl-26802114

ABSTRACT

Stability and change in early autism spectrum disorder risk were examined in a cohort of 99 preterm infants (⩽34 weeks of gestation) using the Autism Observation Scale for Infants at 8 and 12 months and the Autism Diagnostic Observation Schedule-Toddler Module at 18 months. A total of 21 infants were identified at risk by the Autism Observation Scale for Infants at 8 months, and 9 were identified at risk at 12 months, including 4 children who were not previously identified. At 18 months, eight children were identified at risk for autism spectrum disorder using the Autism Diagnostic Observation Schedule-Toddler Module, only half of whom had been identified using the original Autism Observation Scale for Infants cutoffs. Results are discussed in relation to early trajectories of autism spectrum disorder risk among preterm infants as well as identifying social-communication deficiencies associated with the early preterm behavioral phenotype.


Subject(s)
Autism Spectrum Disorder/diagnosis , Infant, Premature , Cohort Studies , Female , Humans , Infant , Male , Risk Assessment
19.
Int J Gynaecol Obstet ; 132(2): 196-9, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26476582

ABSTRACT

OBJECTIVE: To assess the effect of maternal age on preterm neonates' survival free from major morbidity at discharge from two neonatal intensive care units in Jerusalem, Israel. METHODS: A retrospective chart review of two hospitals from 2009-2010 was performed. Eligible neonates were born at less than 35 weeks of gestation and survived to discharge. Major morbidity included at least one of the following: chronic lung disease, at least grade 3 intraventricular hemorrhage, periventricular leukomalacia, at least stage 3 retinopathy of prematurity, at least stage 2 necrotizing enterocolitis, or sepsis. RESULTS: The analysis was performed on 380 neonates of 294 mothers. Mean maternal age was 30.5 years (range, 17-52), mean gestational age was 31.5 weeks (range, 24-34), and mean birth weight was 1705.5 g (range, 460-3150). Of the neonates, 90 (23.7%) had major morbidity, which was associated with lower mean gestational age (29.5 weeks vs 32.3 weeks, P<0.001), birth weight (1326.5g vs 1822.2g, P<0.001), and the need for resuscitation at birth (P<0.001) in comparison with neonates without major morbidity. A comparison of maternal age between the two outcome groups yielded a nonsignificant result. A logistic regression model revealed that maternal age does not contribute significantly to poor neonatal outcomes. CONCLUSION: Advanced maternal age was not associated with major morbidity of preterm neonates at discharge from the neonatal intensive care units.


Subject(s)
Infant, Premature, Diseases/epidemiology , Infant, Premature , Intensive Care Units, Neonatal/statistics & numerical data , Maternal Age , Patient Discharge/statistics & numerical data , Adolescent , Adult , Age Factors , Birth Weight , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature, Diseases/etiology , Israel/epidemiology , Male , Middle Aged , Morbidity , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...